EMAIL THIS PAGE TO A FRIEND

Microbiological research

Antibacterial activity and genotypic-phenotypic characteristics of bacteriocin-producing Bacillus subtilis KKU213: potential as a probiotic strain.


PMID 25440998

Abstract

The antimicrobial activity and probiotic properties of Bacillus subtilis strain KKU213, isolated from local soil, were investigated. The cell-free supernatant (CFS) of a KKU213 culture containing crude bacteriocins exhibited inhibitory effects on Gram-positive bacteria, including Bacillus cereus, Listeria monocytogenes, Micrococcus luteus, and Staphylococcus aureus. The antibacterial activity of the CFS precipitated with 40% ammonium sulfate (AS) remained even after treatment at 60 and 100 °C, at pH 4 and 10 and with proteolytic enzymes, detergents and heavy metals. When analyzed by SDS-PAGE and overlaid with the indicator strains B. cereus and S. aureus, the 40% AS precipitate exhibited inhibitory activity on proteins smaller than 10 kDa. However, proteins larger than 25 kDa and smaller than 10 kDa were still observed on a native protein gel. Purified subtilosin A was prepared by Amberlite XAD-16 bead extraction and HPLC and analyzed by Nano-LC-QTOF-MS. Its molecular mass was found to be 3.4 kDa, and it retained its antibacterial activity. These results are consistent with the detection of the anti-listerial subtilosin A gene of the sbo/alb cluster in the KKU213 strain, which is 100% identical to that of B. subtilis subsp. subtilis 168. In addition to stable and cyclic subtilosin A, a mixture of many extracellular antibacterial peptides was also detected in the KKU213 culture. The KKU213 strain produced extracellular amylase, cellulase, lipase and protease, is highly acid-resistant (pH 2) when cultured in inulin and promotes health and reduces infection of intestinally colonized broiler chickens. Therefore, we propose that bacteriocin-producing B. subtilis KKU213 could be used as a potential probiotic strain or protective culture.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

A0368000 Amikacin, European Pharmacopoeia (EP) Reference Standard
C22H43N5O13
1019508 Amikacin, United States Pharmacopeia (USP) Reference Standard
C22H43N5O13
75199
Azithromycin, analytical standard
C38H72N2O12
Y0000306
Azithromycin, European Pharmacopoeia (EP) Reference Standard
C38H72N2O12
1046056
Azithromycin, United States Pharmacopeia (USP) Reference Standard
C38H72N2O12 · 2H2O
Y0000637
Azithromycin for peak identification, European Pharmacopoeia (EP) Reference Standard
C38H72N2O12
Y0000641
Azithromycin for system suitability, European Pharmacopoeia (EP) Reference Standard
C38H72N2O12
1046067
Azithromycin Identity, United States Pharmacopeia (USP) Reference Standard
C38H72N2O12
17849
Enrofloxacin, ≥98.0% (HPLC)
C19H22FN3O3
33699
Enrofloxacin, VETRANAL, analytical standard
C19H22FN3O3
Y0001259
Enrofloxacin, European Pharmacopoeia (EP) Reference Standard
C19H22FN3O3
1235900
Enrofloxacin, United States Pharmacopeia (USP) Reference Standard
C19H22FN3O3
PHR1513
Enrofloxacin, Pharmaceutical Secondary Standard; Certified Reference Material
C19H22FN3O3
Y0001160
Enrofloxacin for system suitability, European Pharmacopoeia (EP) Reference Standard
C19H22FN3O3
N8878
Nalidixic acid, ≥98%
C12H12N2O3
N5035
Nalidixic acid, meets USP testing specifications
C12H12N2O3
1451000
Nalidixic acid, United States Pharmacopeia (USP) Reference Standard
C12H12N2O3
97023
Nalidixic acid, analytical standard
C12H12N2O3
N0050000
Nalidixic acid, European Pharmacopoeia (EP) Reference Standard
C12H12N2O3
N7878
Nitrofurantoin, crystalline
C8H6N4O5
46502
Nitrofurantoin, VETRANAL, analytical standard
C8H6N4O5
1464001
Nitrofurantoin, United States Pharmacopeia (USP) Reference Standard
C8H6N4O5
PHR1191
Nitrofurantoin, Pharmaceutical Secondary Standard; Certified Reference Material
C8H6N4O5
51239
Oxytetra Selective Supplement, for microbiology
C22H24N2O9
1491004
Oxytetracycline, United States Pharmacopeia (USP) Reference Standard
C22H24N2O9 · 2H2O
PHR1537
Oxytetracycline, Pharmaceutical Secondary Standard; Certified Reference Material
C22H24N2O9 · 2H2O
S7507
Sulfamethoxazole, analytical standard
C10H11N3O3S
76177
Sulfamethoxazole, certified reference material, TraceCERT®
C10H11N3O3S
31737
Sulfamethoxazole, VETRANAL, analytical standard
C10H11N3O3S
PHR1126
Sulfamethoxazole, Pharmaceutical Secondary Standard; Certified Reference Material
C10H11N3O3S